Risk Paradigm Group’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Risk Paradigm Group’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-557	Closed	-$30K	–	264
2017 Q4	$30K	Sell	557 -10	-2%	-$547	0.03%	190
2017 Q3	$32.4K	Sell	567 -12	-2%	-$703	0.04%	169
2017 Q2	$34.8K	Buy	579 +289	+100%	+$16.5K	0.04%	166
2017 Q1	$15.8K	Buy	+290	New	+$14.3K	0.02%	207

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Risk Paradigm Group's BIVV Position: Q1 2018 in Review

Risk Paradigm Group sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 557 shares — an estimated $30K sold.

Risk Paradigm Group first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $34.8K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Risk Paradigm Group reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Risk Paradigm Group sold 557 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $30K.
Risk Paradigm Group first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Risk Paradigm Group's Bioverativ Inc. Common Stock position peaked at $34.8K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Risk Paradigm Group's 13F filing for Q1 2018, filed 15 May 2018.